We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

134 hedge funds and large institutions have $61.3M invested in SANGAMO THERAPEUTICS INC in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $91K | Put options by funds: $81K

3.95% less ownership

Funds ownership: 61.65%57.7% (-4%)

12% less funds holding

Funds holding: 152134 (-18)

33% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 49

55% less capital invested

Capital invested by funds: $137M → $61.3M (-$76.1M)

65% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 26

Holders
134
Holders Change
-18
Holders Change %
-11.84%
% of All Funds
2.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
33
Reduced
49
Closed
26
Calls
$91K
Puts
$81K
Net Calls
+$10K
Net Calls Change
+$87K

SGMO Hedge Fund Activity: Q3 2023 in Review

134 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2023, worth a combined $61.3M — down 55% from $137M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SGMO and 9 opened new positions — a net loss of 17 holders — while 49 trimmed existing stakes and 33 added.

The largest buyer was Wasatch Advisors, adding an estimated $1M. The largest seller was Globeflex Capital, exiting entirely with an estimated $907K sold.

  • 134 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2023, down from 152 in Q2 2023.
  • Funds reported $61.3M of SANGAMO THERAPEUTICS INC stock for Q3 2023, down 55% quarter-over-quarter.
  • 9 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2023 and 26 closed out, a net change of -17 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2023 was Wasatch Advisors, an estimated $1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2023 was Globeflex Capital, an estimated $907K sold.

Based on aggregated 13F filings for Q3 2023.